NEPHRAMINE 5.4% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nephramine 5.4%, and when can generic versions of Nephramine 5.4% launch?
Nephramine 5.4% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in NEPHRAMINE 5.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nephramine 5.4%
A generic version of NEPHRAMINE 5.4% was approved as amino acids by B BRAUN on April 13th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEPHRAMINE 5.4%?
- What are the global sales for NEPHRAMINE 5.4%?
- What is Average Wholesale Price for NEPHRAMINE 5.4%?
Summary for NEPHRAMINE 5.4%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEPHRAMINE 5.4% at DailyMed |
![NEPHRAMINE 5.4% drug patent expirations Drug patent expirations by year for NEPHRAMINE 5.4%](/p/graph/s/t/NEPHRAMINE_5.4%-patent-expirations.png)
US Patents and Regulatory Information for NEPHRAMINE 5.4%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | NEPHRAMINE 5.4% | amino acids | INJECTABLE;INJECTION | 017766-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |